An appraisal of natural products active against parasitic nematodes of animals
Abstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-019-3537-1 |
id |
doaj-b14af5b8c2d447e7bea5fcfc07284582 |
---|---|
record_format |
Article |
spelling |
doaj-b14af5b8c2d447e7bea5fcfc072845822020-11-25T03:50:06ZengBMCParasites & Vectors1756-33052019-06-0112112210.1186/s13071-019-3537-1An appraisal of natural products active against parasitic nematodes of animalsJose F. Garcia-Bustos0Brad E. Sleebs1Robin B. Gasser2Faculty of Veterinary and Agricultural Sciences, The University of MelbourneWalter and Eliza Hall Institute of Medical ResearchFaculty of Veterinary and Agricultural Sciences, The University of MelbourneAbstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the model nematode Caenorhabditis elegans have been analysed. Scientific articles published since 2010 and patents granted from 2000, both inclusive, have been included in this analysis. The results show a scarcity of novel chemical structures, a limited follow-up of compounds disclosed before 2010 and a bias towards the screening of plant products, almost to the exclusion of other sources, when microbial extracts have, historically, provided most starting points for anti-infective drugs. All plant products published in this period were previously known, alerting to the high re-discovery rates of a limited number of chemical classes from this source. The most promising compounds described in the literature reviewed here, namely the linear nemadectin-derivatives, are novel and of bacterial origin. Patented but otherwise unpublished spiroketal structures also appear as interesting scaffolds for future development. The patent literature confirmed that it is possible to patent derivatives of previously known products, making them valid starting points for translational research.http://link.springer.com/article/10.1186/s13071-019-3537-1AnimalsAnthelminticsNatural productsNematocides |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jose F. Garcia-Bustos Brad E. Sleebs Robin B. Gasser |
spellingShingle |
Jose F. Garcia-Bustos Brad E. Sleebs Robin B. Gasser An appraisal of natural products active against parasitic nematodes of animals Parasites & Vectors Animals Anthelmintics Natural products Nematocides |
author_facet |
Jose F. Garcia-Bustos Brad E. Sleebs Robin B. Gasser |
author_sort |
Jose F. Garcia-Bustos |
title |
An appraisal of natural products active against parasitic nematodes of animals |
title_short |
An appraisal of natural products active against parasitic nematodes of animals |
title_full |
An appraisal of natural products active against parasitic nematodes of animals |
title_fullStr |
An appraisal of natural products active against parasitic nematodes of animals |
title_full_unstemmed |
An appraisal of natural products active against parasitic nematodes of animals |
title_sort |
appraisal of natural products active against parasitic nematodes of animals |
publisher |
BMC |
series |
Parasites & Vectors |
issn |
1756-3305 |
publishDate |
2019-06-01 |
description |
Abstract Here, the scientific and patent literature on the activities of purified natural compounds has been reviewed, with the aim of assessing their suitability as anthelmintic drug discovery starting points. Only compounds described as active against parasitic nematodes of animals or against the model nematode Caenorhabditis elegans have been analysed. Scientific articles published since 2010 and patents granted from 2000, both inclusive, have been included in this analysis. The results show a scarcity of novel chemical structures, a limited follow-up of compounds disclosed before 2010 and a bias towards the screening of plant products, almost to the exclusion of other sources, when microbial extracts have, historically, provided most starting points for anti-infective drugs. All plant products published in this period were previously known, alerting to the high re-discovery rates of a limited number of chemical classes from this source. The most promising compounds described in the literature reviewed here, namely the linear nemadectin-derivatives, are novel and of bacterial origin. Patented but otherwise unpublished spiroketal structures also appear as interesting scaffolds for future development. The patent literature confirmed that it is possible to patent derivatives of previously known products, making them valid starting points for translational research. |
topic |
Animals Anthelmintics Natural products Nematocides |
url |
http://link.springer.com/article/10.1186/s13071-019-3537-1 |
work_keys_str_mv |
AT josefgarciabustos anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals AT bradesleebs anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals AT robinbgasser anappraisalofnaturalproductsactiveagainstparasiticnematodesofanimals AT josefgarciabustos appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals AT bradesleebs appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals AT robinbgasser appraisalofnaturalproductsactiveagainstparasiticnematodesofanimals |
_version_ |
1724492323711090688 |